A potential therapeutic vaccine strategy for a subset of myeloproliferative neoplasms

by Ludwig Cancer ResearchCredit: CC0 Public DomainThe cells of a subset of myeloproliferative neoplasms (MPNs), slow-growing blood cancers, have frameshift mutations in their calreticulin (CALR)

Updated on: January 29,2024 11

A potential therapeutic vaccine strategy for a subset of myeloproliferative neoplasms

by Ludwig Cancer ResearchCredit: CC0 Public DomainThe cells of a subset of myeloproliferative neoplasms (MPNs), slow-growing blood cancers, have frameshift mutations in their calreticulin (CALR)

Updated on:January 29,2024 11

The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

by Karolinska InstitutetCredit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2310479121Anew studyfrom Karolinska Institutet discovered that bloc

Updated on: March 05,2024 6

The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

by Karolinska InstitutetCredit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2310479121Anew studyfrom Karolinska Institutet discovered that bloc

Updated on:March 05,2024 6

Entering the golden age for antibody-drug conjugates in gynecologic cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainIn an editorial, published inOncosciencetitled, "Entering the golden age for antibody-drug conjugates in gynecologic cancer,&quo

Updated on: July 17,2024 0

Entering the golden age for antibody-drug conjugates in gynecologic cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainIn an editorial, published inOncosciencetitled, "Entering the golden age for antibody-drug conjugates in gynecologic cancer,&quo

Updated on:July 17,2024 0

Novel approach to study hypoxia enables identification of a marker for ovarian cancers

by Myreille Larouche,University of MontrealLong-term severe hypoxia adaptation induces EMT-like morphological changes. Credit:Cancer Gene Therapy(2024). DOI: 10.1038/s41417-024-00795

Updated on: August 28,2024 0

Novel approach to study hypoxia enables identification of a marker for ovarian cancers

by Myreille Larouche,University of MontrealLong-term severe hypoxia adaptation induces EMT-like morphological changes. Credit:Cancer Gene Therapy(2024). DOI: 10.1038/s41417-024-00795

Updated on:August 28,2024 0

Mathematical methods for diagnosing breast cancer

by Kaunas University of Technology100 microscope images of breast tissue were analyzed in order to teach computer to recognize malignancy; 85 percent accuracy rate was achieved. Credit: KTUA team

Updated on: April 14,2024 20

Mathematical methods for diagnosing breast cancer

by Kaunas University of Technology100 microscope images of breast tissue were analyzed in order to teach computer to recognize malignancy; 85 percent accuracy rate was achieved. Credit: KTUA team

Updated on:April 14,2024 20

Researchers identify the mutations that drive resistance to PI3K inhibitors in breast cancer, find they can be overcome

by Mass General BrighamSecondary mutations in the PI3K/AKT pathway emerge during treatment with inavolisib and lead to acquired resistance. A-B, Droplet digital PCR analysis of serial ctDNA sampl

Updated on: June 24,2024 8

Researchers identify the mutations that drive resistance to PI3K inhibitors in breast cancer, find they can be overcome

by Mass General BrighamSecondary mutations in the PI3K/AKT pathway emerge during treatment with inavolisib and lead to acquired resistance. A-B, Droplet digital PCR analysis of serial ctDNA sampl

Updated on:June 24,2024 8

Study identifies a genetic driver of deadly prostate cancer

by Cedars-Sinai Medical CenterGraph shows elevated activity of a transcription-factor network that includes the molecule Onecut2 in tumors of patients whose prostate cancer resisted hormone thera

Updated on: March 12,2024 19

Study identifies a genetic driver of deadly prostate cancer

by Cedars-Sinai Medical CenterGraph shows elevated activity of a transcription-factor network that includes the molecule Onecut2 in tumors of patients whose prostate cancer resisted hormone thera

Updated on:March 12,2024 19

Drug-pricing program improves prostate cancer treatment adherence, finds study

by Nicole Fawcett,University of MichiganCredit: Unsplash/CC0 Public DomainProstate cancer patients receiving care at hospitals that are part of a special drug-pricing program were more likely to

Updated on: March 30,2024 0

Drug-pricing program improves prostate cancer treatment adherence, finds study

by Nicole Fawcett,University of MichiganCredit: Unsplash/CC0 Public DomainProstate cancer patients receiving care at hospitals that are part of a special drug-pricing program were more likely to

Updated on:March 30,2024 0

Triplet therapy including belamaf prolongs survival in multiple myeloma

by Elana GotkineFor patients with relapsed or refractory multiple myeloma (RRMM), triplet therapy of belantamab mafodotin (belamaf) plus bortezomib and dexamethasone (BVd) improves outcomes, with an a

Updated on: March 24,2024 16

Triplet therapy including belamaf prolongs survival in multiple myeloma

by Elana GotkineFor patients with relapsed or refractory multiple myeloma (RRMM), triplet therapy of belantamab mafodotin (belamaf) plus bortezomib and dexamethasone (BVd) improves outcomes, with an a

Updated on:March 24,2024 16

Prostate cancer: Getting ever closer to diagnosis using an 'electronic nose'

by Politecnico di MilanoPrototype of an electronic nose developed by the Politecnico di Milano in partnership with Humanitas, capable of diagnosing a tumor using a urine sample with 82% accuracy. Cred

Updated on: January 02,2024 13

Prostate cancer: Getting ever closer to diagnosis using an 'electronic nose'

by Politecnico di MilanoPrototype of an electronic nose developed by the Politecnico di Milano in partnership with Humanitas, capable of diagnosing a tumor using a urine sample with 82% accuracy. Cred

Updated on:January 02,2024 13

New research: Immune cells that fight cancer become exhausted within hours of first encountering tumors

by Mary Philip and Michael Rudloff,The ConversationThis microscopy image shows a cytotoxic T cell (blue) attacking a cancer cell (green) by releasing toxic chemicals (red). Credit:Alex Rit

Updated on: January 12,2024 10

New research: Immune cells that fight cancer become exhausted within hours of first encountering tumors

by Mary Philip and Michael Rudloff,The ConversationThis microscopy image shows a cytotoxic T cell (blue) attacking a cancer cell (green) by releasing toxic chemicals (red). Credit:Alex Rit

Updated on:January 12,2024 10

Evidence supports three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

by Regenstrief InstituteCredit: Unsplash/CC0 Public DomainA scientific study exploring the appropriate interval for colorectal cancer screening via non-invasive multi-target stool DNA testing for

Updated on: February 03,2024 11

Evidence supports three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

by Regenstrief InstituteCredit: Unsplash/CC0 Public DomainA scientific study exploring the appropriate interval for colorectal cancer screening via non-invasive multi-target stool DNA testing for

Updated on:February 03,2024 11